Aging brains may not be permanent: Scientists reverse memory loss by reducing a single protein

Aging brains often brings concerns about memory loss and slowing cognition, but scientists say that decline may not be as inevitable as once believed. A study suggests that a single protein could play a key role in age-related cognitive dysfunction and that its effects may even be reversible, at least in animal models.

Researchers at the University of California, San Francisco, have identified a protein linked to brain aging and demonstrated that reducing its levels restored memory performance in older mice and ‘regained their youth.’ The findings, published by scientists at the university’s Bakar Aging Research Institute, point to potential future treatments that could reveal a method of slowing or reversing cognitive decline.

How the study on aging brains conducted in mice

The team focused on the hippocampus, a critical region of the brain involved in learning and memory. Comparing young and old mice, researchers found that older brains, unlike younger ones, were flooded with a protein known as FTL1.

To determine whether the protein was driving the decline, scientists increased FTL1 levels in young mice. Their brains soon began to resemble those of older animals, with neurons losing complex branching structures and forming shorter, less effective connections.

Also Read: Sperm whale giving birth video analysis shows 11 whales helping newborn stay afloat

Reducing the protein led the old mice behave like younger ones

When researchers reduced FTL1 levels in older mice, the results were striking. Lowering the protein did not merely slow deterioration — it helped rebuild connections in the hippocampus and repair existing damage. Treated mice subsequently performed better on memory tests.

“It is truly a reversal of impairments,” says Saul Villeda, PhD, the study’s senior author. “It’s much more than merely delaying or preventing symptoms.”

The study also explored how the protein contributes to cognitive decline. High levels of FTL1 appeared to slow energy production within brain cells, acting as a metabolic brake. Without adequate energy, neural connections weakened and communication between synapses diminished.

Aging brain reversal study in mice gives hope to scientists

While the research is still limited to mice, scientists are hopeful that the findings offer hope for future therapies targeting age-related cognitive decline in humans. Although medically approved treatments may still be years away, the results suggest that brain aging could potentially be treated as a manageable biological process rather than an irreversible condition.

“We’re seeing more opportunities to alleviate the worst consequences of old age,” said Villeda, Endowed Professor of Biomedical Sciences. “It’s a hopeful time to be working on the biology of aging.”